Works matching DE "PEMBROLIZUMAB"

Results: 1309

US FDA approves pembrolizumab as first‐line treatment for patients with HER2‐positive advanced gastric or gastroesophageal junction adenocarcinoma.

Published in:

Cancer (0008543X), 2025, v. 131, n. 14, p. 1, doi. 10.1002/cncr.35925

By:

Nierengarten, Mary Beth

Publication type:

Article

Spatial biomarkers of response to eribulin plus pembrolizumab in patients with metastatic triple negative breast cancer in the ENHANCE-1 trial.

Published in:

NPJ Breast Cancer, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41523-025-00791-2

By:

Foong, Yee Hoon;
Wang, Qi;
Kearney, Matthew;
Le, Hortense;
Guo, Hua;
Chen, Diane;
Politis, Michelle Garlin;
Connelly, Courtney F.;
Kalinsky, Kevin;
Vanguri, Rami S.;
Connolly, Eileen P.

Publication type:

Article

Combination of Lenvatinib and pembrolizumab as neoadjuvant treatment for BRAF negative anaplastic thyroid cancer.

Published in:

ANZ Journal of Surgery, 2025, v. 95, n. 6, p. 1271, doi. 10.1111/ans.70104

By:

Jie, Zhao;
Nguyen, Bella;
Lisewski, Dean

Publication type:

Article

Effect of Pembrolizumab on Lymph Node Dissection in Patients Who Experienced Bladder Cancer Recurrence Following Radical Cystectomy.

Published in:

In Vivo, 2025, v. 39, n. 4, p. 2196, doi. 10.21873/invivo.14015

By:

YOSHIHIKO TASAKI;
TAKASHI NAGAI;
TAKU NAIKI;
YUSUKE NODA;
RYOSEI OKAWA;
MISATO TOMITA;
YOSUKE SUGIYAMA;
YOSHIHISA MIMURA;
KUNIHIRO ODAGIRI;
NANAMI ITO;
YUJI HOTTA;
NOBUHIKO SHIMIZU;
TOSHIKI ETANI;
SHUZO HAMAMOTO;
ATSUSHI OKADA;
YOKO FURUKAWA-HIBI;
TAKAHIRO YASUI

Publication type:

Article

Pembrolizumab versus Pembrolizumab plus Chemotherapy in Non-small Cell Lung Cancer with High PD-L1 Expression -- Multicenter Real-world Evidence Study.

Published in:

Journal of Cancer, 2025, v. 16, n. 10, p. 3015, doi. 10.7150/jca.113815

By:

Svaton, Martin;
Knetki-Wroblewska, Magdalena;
Hosek, Petr;
Chowaniecova, Gabriela;
Spacek, Jan;
Fischer, Ondrej;
Bilek, Ondrej;
Hrnciarik, Michal;
Kauffmann-Guerrero, Diego

Publication type:

Article

LC-MS determination of Nicotiana benthamiana host plant proteins in the drug products of recombinant plant-produced pembrolizumab.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-11541-6

By:

Daduang, Ratama;
Suwanchaikasem, Pipob;
Rattanapisit, Kaewta;
Vitayathikornnasak, Sarocha;
Srisangsung, Theerakarn;
Bulaon, Christine Joy I.;
Phoolcharoen, Waranyoo

Publication type:

Article

Critical Needs and Opportunities for Advanced Manufacturing of Lyophilized Injectables.

Published in:

Pharmaceutical Research, 2025, v. 42, n. 6, p. 1059, doi. 10.1007/s11095-025-03869-5

By:

Alexeenko, Alina;
Korang-Yeboah, Maxwell;
Tchessalov, Serguei

Publication type:

Article

Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer.

Published in:

Thyroid, 2025, v. 35, n. 7, p. 763, doi. 10.1089/thy.2025.0194

By:

Cabanillas, Maria E.;
Busaidy, Naifa L.;
Gunn, G. Brandon;
Iyer, Priyanka C.;
Ferrarotto, Renata;
Gule-Monroe, Maria;
Maniakas, Anastasios;
Williams, Michelle D.;
Liu, Suyu;
Fellman, Bryan;
Spiotto, Michael;
Hamidi, Sarah;
Akhave, Neal;
Lee, Anna;
Wang, Jennifer R.;
de Sousa, Luana;
Marczyk, Vicente R.;
Zafereo, Mark;
Dadu, Ramona

Publication type:

Article

Focus on PD-1/PD-L1-Targeting Antibodies in Colorectal Cancer: Are There Options Beyond Dostarlimab, Nivolumab, and Pembrolizumab? A Comprehensive Review.

Published in:

Molecules, 2025, v. 30, n. 13, p. 2686, doi. 10.3390/molecules30132686

By:

Kciuk, Mateusz;
Wanke, Katarzyna;
Kruczkowska, Weronika;
Marciniak, Beata;
Kontek, Renata

Publication type:

Article

Pembrolizumab promotes degradation of cyclin dependent kinase 6 and suppresses ovarian cancer progression in vitro.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-11043-5

By:

Wu, Yi;
Xu, Ziyan;
Kou, Zuqiang;
Ye, Qiuling;
Chen, Liting;
Gou, Boyu

Publication type:

Article

Clinical outcomes of pembrolizumab plus chemotherapy for postoperative recurrent esophageal squamous cell carcinoma.

Published in:

Diseases of the Esophagus, 2025, v. 38, n. 3, p. 1, doi. 10.1093/dote/doaf029

By:

Sugase, Takahito;
Kanemura, Takashi;
Matsuura, Norihiro;
Sugimura, Keijiro;
Takeoka, Tomohira;
Ushimaru, Yuki;
Masuike, Yasunori;
Yanagimoto, Yoshitomo;
Mori, Ryota;
Kitakaze, Masatoshi;
Kubo, Masahiko;
Mukai, Yosuke;
Komatsu, Hisateru;
Sueda, Toshinori;
Kagawa, Yoshinori;
Nishimura, Junichi;
Wada, Hiroshi;
Yasui, Masayoshi;
Miyata, Hiroshi

Publication type:

Article

Changing landscape of first-line treatment for locally advanced or metastatic urothelial carcinoma: the progression from platinum-based chemotherapy to platinum-free therapy.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1604395

By:

Liu, Zengguang;
Chen, Chen;
Yin, Jiaxin;
Cong, Xiaofeng;
Liu, Ziling

Publication type:

Article

Adverse event profile of five anti head and neck squamous cell carcinoma drugs: a descriptive analysis from WHO-VigiAccess.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1602276

By:

Gao, Weimin;
Xia, Zhigang;
Zhou, Tingfeng;
Dong, Youlin

Publication type:

Article

PD-1 monoclonal antibodies as an effective treatment for rare cutaneous malignancies: a case report.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1609767

By:

Falk, Ryan;
Samlowski, Wolfram;
Hedayat, Amin

Publication type:

Article

A phase II single-arm study of combination pembrolizumab and olaparib in the treatment of patients with advanced biliary tract cancer.

Published in:

NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-01009-1

By:

Sadagopan, Narayanan;
Wang, Hongkun;
Yin, Chao;
Weinberg, Benjamin Adam;
Noel, Marcus Smith;
Mukherji, Reetu;
Geng, Xue;
Marshall, John Lindsay;
He, Aiwu Ruth

Publication type:

Article

A phase-2 study of pembrolizumab in patients with biologically selected subtypes of relapsed/refractory aggressive lymphomas.

Published in:

2025

By:

Merrill, Mwanasha H.;
Redd, Robert A.;
Fisher, David C.;
Abramson, Jeremy S.;
Barnes, Jeffrey;
Choi, Jaehyuk;
Jacobson, Caron A.;
Kim, Austin I.;
Lunning, Matthew A.;
Jester, Hallie D.;
Jeter, Erin L.;
McDonough, Mikaela M.;
Armand, Philippe;
Jacobsen, Eric D.

Publication type:

Letter to the Editor

Cytokine Release Syndrome Induced by Pembrolizumab for Metastatic Anal Melanoma.

Published in:

2025

By:

Martel, Erica;
Li, Shijia;
Hoteit, Mayssaa;
Bham, Zubin;
Nishimura, Yoshito

Publication type:

Case Study

Polymyalgia Rheumatica (PMR) and Polymyalgia Rheumatica-like (PMR-like) Manifestations in Cancer Patients Following Treatment with Nivolumab and Pembrolizumab: Methodological Blurred Points Identified Through a Systematic Review of Published Case Reports.

Published in:

Medical Sciences, 2025, v. 13, n. 2, p. 34, doi. 10.3390/medsci13020034

By:

Manzo, Ciro;
Isetta, Marco;
Castagna, Alberto;
Kechida, Melek

Publication type:

Article

Neurological adverse effects due to programmed death 1 (PD-1) inhibitors.

Published in:

Journal of Neuro-Oncology, 2020, v. 148, n. 2, p. 291, doi. 10.1007/s11060-020-03514-8

By:

Shi, Siyu;
Jaoube, Joseph Abi;
Kanwar, Ruhi;
Jin, Michael C.;
Amorin, Alvaro;
Varanasi, Vamsi;
Eisinger, Ella;
Thomas, Reena;
Moore, Justin M.

Publication type:

Article

Pembrolizumab for primary malignant melanoma of the central nervous system.

Published in:

2018

By:

El Habnouni, Chakib;
Bléchet, Claire;
Bens, Guido

Publication type:

Letter to the Editor

Comparing available criteria for measuring brain metastasis response to immunotherapy.

Published in:

Journal of Neuro-Oncology, 2017, v. 132, n. 3, p. 479, doi. 10.1007/s11060-017-2398-8

By:

Qian, Jack;
Mahajan, Amit;
Yu, James;
Tsiouris, A.;
Goldberg, Sarah;
Kluger, Harriet;
Chiang, Veronica

Publication type:

Article

Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 453, doi. 10.1007/s11060-016-2190-1

By:

Blumenthal, Deborah;
Yalon, Michal;
Vainer, Gilad;
Lossos, Alexander;
Yust, Shlomit;
Tzach, Lior;
Cagnano, Emanuela;
Limon, Dror;
Bokstein, Felix

Publication type:

Article

Advanced non-small-cell lung cancer treated with first-line pembrolizumab plus chemotherapy: tumor response dynamics as a marker for survival.

Published in:

European Radiology, 2023, v. 33, n. 10, p. 7284, doi. 10.1007/s00330-023-09658-1

By:

Nishino, Mizuki;
Wang, Xinan;
Ricciuti, Biagio;
Tseng, Shu-Chi;
Park, Hyesun;
Alessi, Joao V.;
Vaz, Victor R.;
Hatabu, Hiroto;
Lin, Xihong;
Christiani, David C.;
Awad, Mark M.

Publication type:

Article

Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial.

Published in:

European Radiology, 2021, v. 31, n. 4, p. 1853, doi. 10.1007/s00330-020-07249-y

By:

Ahmed, Firas S.;
Dercle, Laurent;
Goldmacher, Gregory V.;
Yang, Hao;
Connors, Dana;
Tang, Ying;
Karovic, Sanja;
Zhao, Binsheng;
Carvajal, Richard D.;
Robert, Caroline;
Maitland, Michael L.;
Oxnard, Geoffrey R.;
Schwartz, Lawrence H.

Publication type:

Article

A retrospective study of pembrolizumab plus chemotherapy for head and neck cancer patients: influence of response in combination phase on subsequent maintenance phase.

Published in:

Discover Oncology, 2025, p. 1, doi. 10.1007/s12672-025-02256-1

By:

Saijo, Ken;
Imai, Hiroo;
Kasahara, Yuki;
Numakura, Ryunosuke;
Ueta, Reio;
Sasaki, Keiju;
Yoshida, Yuya;
Umegaki, Sho;
Taniguchi, Sakura;
Ouchi, Kota;
Komine, Keigo;
Shirota, Hidekazu;
Takahashi, Masanobu;
Ishioka, Chikashi

Publication type:

Article

Medication‐Induced Lichen Sclerosus: A Systematic Review.

Published in:

2025

By:

Alyousef, Samar;
Alqahtani, Lama;
Shadid, Asem;
Almashali, Mohammed

Publication type:

Literature Review

Pembrolizumab in combination with chemotherapy in patients with advanced squamous cell lung cancer -- clinical trials and real-world data.

Published in:

Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 3, p. 209, doi. 10.5603/OCP.2023.0047

By:

Knetki-Wróblewska, Magdalena;
Kowalski, Dariusz M.

Publication type:

Article

Optimizing treatment strategies for a MET exon 14 skipping mutation in non-small-cell lung cancer: a case report of sequential immunotherapy and targeted therapy and literature review.

Published in:

Oncology in Clinical Practice (2450-1654), 2023, v. 19, n. 6, p. 448, doi. 10.5603/OCP.2023.0041

By:

Grodkiewicz, Maria;
Kozieł, Paweł;
Chmielewska, Izabela;
Krawczyk, Paweł;
Milanowski, anusz

Publication type:

Article

Recent advances in the treatment of triple-negative breast cancer.

Published in:

Oncology in Clinical Practice (2450-1654), 2023, v. 19, n. 6, p. 433, doi. 10.5603/OCP.2022.0056

By:

Pogoda, Katarzyna;
Jagiełło-Gruszfeld, Agnieszka;
Kunkiel, Michał;
Niwińska, Anna;
Nowecki, Zbigniew

Publication type:

Article

Hypopituitarism as a rare complication of lung cancer immunotherapy.

Published in:

Oncology in Clinical Practice (2450-1654), 2023, v. 19, n. 3, p. 203, doi. 10.5603/OCP.2023.0013

By:

Gałązka, Jakub Krzysztof;
Rudzińska, Anna;
Rudzki, Grzegorz;
Szklener, Katarzyna;
Mańdziuk, Sławomir

Publication type:

Article

Immunotherapy with pembrolizumab in a patient with advanced non-small-cell lung cancer with high PD-L1 expression and MET exon 14 splice site mutation.

Published in:

Oncology in Clinical Practice (2450-1654), 2023, v. 19, n. 1, p. 63, doi. 10.5603/OCP.2022.0007

By:

Terlecka, Paulina;
Krawczyk, Paweł;
Grenda, Anna;
Chmielewska, Izabela;
Milanowski, Janusz

Publication type:

Article

COVID-19 infection during treatment with pembrolizumab in combination with chemotherapy for the treatment of lung adenocarcinoma.

Published in:

Oncology in Clinical Practice (2450-1654), 2022, v. 18, n. 6, p. 406, doi. 10.5603/OCP.2022.0023

By:

Wójcik-Superczyńska, Magdalena

Publication type:

Article

The search for causes of resistance to pembrolizumab in lung adenocarcinoma with PD-L1 expression -- focus on intestinal microbiome.

Published in:

Oncology in Clinical Practice (2450-1654), 2020, v. 16, n. 6, p. 364, doi. 10.5603/OCP.2020.0031

By:

Grenda, Anna;
Iwan, Ewelina;
Krawczyk, Paweł;
Chmielewska, Izabela;
Jarosz, Bożena;
Reszka, Katarzyna;
Kucharczyk, Tomasz;
Wojas-Krawczyk, Kamila;
Gil, Michał;
Słomiany-Szwarc, Magdalena;
Bomba, Arkadiusz;
Wasyl, Dariusz;
Milanowski, Janusz

Publication type:

Article

New dosing schedule of pembrolizumab -- theoretical basis and scientific evidence.

Published in:

Oncology in Clinical Practice (2450-1654), 2020, v. 16, n. 6, p. 358, doi. 10.5603/OCP.2020.0033

By:

Szcześ, Dorota;
Rutkowski, Piotr

Publication type:

Article

Indirect comparison of treating patients with advanced/metastatic melanoma with nivolumab or pembrolizumab -- multicenter analysis.

Published in:

Oncology in Clinical Practice (2450-1654), 2020, v. 16, n. 5, p. 295, doi. 10.5603/OCP.2020.0037

By:

Cybulska-Stopa, Bożena;
Ziętek, Marcin;
Kamińska-Winciorek, Grażyna;
Czarnecka, Anna M.;
Piejko, Karolina;
Galus, Łukasz;
Ziółkowska, Barbara;
Kieszko, Stanisław;
Kempa-Kamińska, Natasza;
Calik, Jacek;
Kubiatowski, Tomasz;
Suwiński, Rafał;
Mackiewicz, Jacek;
Rutkowski, Piotr

Publication type:

Article

An update on the epidemiology, imaging and therapy of brain metastases.

Published in:

Nowotwory, 2020, v. 70, n. 3, p. 111, doi. 10.5603/NJO.2020.0024

By:

Mielczarek, Maciej;
Kubica, Anna;
Szylberg, Mateusz;
Zielińska, Karolina;
Przybył, Jakub;
Sierzputowska, Agata;
Harat, Marek

Publication type:

Article

New developments in the perioperative treatment of melanomas with locoregional advancement.

Published in:

Nowotwory, 2019, v. 69, n. 3/4, p. 97, doi. 10.5603/NJO.2019.0019

By:

Rutkowski, Piotr;
Wysocki, Wojciech M.;
Świtaj, Tomasz;
Jeziorski, Arkadiusz

Publication type:

Article

Lenvatinib Plus Pembrolizumab versus Doxorubicin for Advanced or Recurrent Endometrial Cancer with Short Treatment-Free Intervals Following First-Line Carboplatin Plus Paclitaxel.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 19, p. 5670, doi. 10.3390/jcm13195670

By:

Wang, Shao-Jing;
Chen, Hsin-Hua;
Sun, Lou;
Shih, Yu-Hsiang;
Lu, Ting-Fang;
Chen, Yen-Fu;
Fan, Chun-Ting;
Hsu, Shih-Tien;
Liu, Chin-Ku;
Hwang, Sheau-Feng;
Lu, Chien-Hsing

Publication type:

Article

Ezrin Contributes to the Plasma Membrane Expression of PD–L1 in A2780 Cells.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 9, p. 2457, doi. 10.3390/jcm11092457

By:

Tameishi, Mayuka;
Ishikawa, Honami;
Tanaka, Chihiro;
Kobori, Takuro;
Urashima, Yoko;
Ito, Takuya;
Obata, Tokio

Publication type:

Article

Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1855, doi. 10.3390/jcm11071855

By:

Ushio, Ryota;
Murakami, Shuji;
Saito, Haruhiro

Publication type:

Article

The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1740, doi. 10.3390/jcm11061740

By:

Castello, Angelo;
Castellani, Massimo;
Florimonte, Luigia;
Urso, Luca;
Mansi, Luigi;
Lopci, Egesta

Publication type:

Article

Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune Checkpoint Inhibitors: A Meta-Analysis.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 4, p. N.PAG, doi. 10.3390/jcm11041038

By:

Rizzo, Alessandro;
Mollica, Veronica;
Santoni, Matteo;
Palmiotti, Gennaro;
Massari, Francesco

Publication type:

Article

PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 7, p. 1365, doi. 10.3390/jcm10071365

By:

Majem, Margarita;
Cobo, Manuel;
Isla, Dolores;
Marquez-Medina, Diego;
Rodriguez-Abreu, Delvys;
Casal-Rubio, Joaquín;
Moran-Bueno, Teresa;
Bernabé-Caro, Reyes;
Pérez-Parente, Diego;
Ruiz-Gracia, Pedro;
Arroyo, Marta Marina;
Paz-Ares, Luis;
De Mello, Ramon Andrade

Publication type:

Article

The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 5, p. 1005, doi. 10.3390/jcm10051005

By:

Lenci, Edoardo;
Cantini, Luca;
Pecci, Federica;
Cognigni, Valeria;
Agostinelli, Veronica;
Mentrasti, Giulia;
Lupi, Alessio;
Ranallo, Nicoletta;
Paoloni, Francesco;
Rinaldi, Silvia;
Nicolardi, Linda;
Caglio, Andrea;
Aerts, Sophie;
Cortellini, Alessio;
Ficorella, Corrado;
Chiari, Rita;
Di Maio, Massimo;
Dingemans, Anne-Marie C.;
Aerts, Joachim G. J. V.;
Berardi, Rossana

Publication type:

Article

Endocrinopathies Associated with Immune Checkpoint Inhibitor Cancer Treatment: A Review.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 7, p. 2033, doi. 10.3390/jcm9072033

By:

Okura, Naoko;
Asano, Mai;
Uchino, Junji;
Morimoto, Yoshie;
Iwasaku, Masahiro;
Kaneko, Yoshiko;
Yamada, Tadaaki;
Fukui, Michiaki;
Takayama, Koichi

Publication type:

Article

Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1769, doi. 10.3390/jcm9061769

By:

Lee, Sang Hoon;
Lee, Hee Seung;
Lee, Sang Hyub;
Woo, Sang Myung;
Kim, Dong Uk;
Bang, Seungmin

Publication type:

Article

Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1721, doi. 10.3390/jcm9061721

By:

Musacchio, Lucia;
Boccia, Serena Maria;
Caruso, Giuseppe;
Santangelo, Giusi;
Fischetti, Margherita;
Tomao, Federica;
Perniola, Giorgia;
Palaia, Innocenza;
Muzii, Ludovico;
Pignata, Sandro;
Benedetti Panici, Pierluigi;
Di Donato, Violante

Publication type:

Article

Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1362, doi. 10.3390/jcm9051362

By:

Onoi, Keisuke;
Chihara, Yusuke;
Uchino, Junji;
Shimamoto, Takayuki;
Morimoto, Yoshie;
Iwasaku, Masahiro;
Kaneko, Yoshiko;
Yamada, Tadaaki;
Takayama, Koichi

Publication type:

Article

Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2089, doi. 10.3390/jcm8122089

By:

Blanch-Lombarte, Oscar;
Gálvez, Cristina;
Revollo, Boris;
Jiménez-Moyano, Esther;
Llibre, Josep M.;
Manzano, José Luís;
Boada, Aram;
Dalmau, Judith;
E. Speiser, Daniel;
Clotet, Bonaventura;
G. Prado, Julia;
Martinez-Picado, Javier

Publication type:

Article

Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 11, p. 1777, doi. 10.3390/jcm8111777

By:

Möhn, Nora;
Beutel, Gernot;
Gutzmer, Ralf;
Ivanyi, Philipp;
Satzger, Imke;
Skripuletz, Thomas

Publication type:

Article